OCG
LFCR icon

Opus Capital Group’s Lifecore Biomedical LFCR Stock Holding History

Opus Capital Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-351,129
Closed -$5.07M – 256
2015
Q2 		$5.07M Sell
351,129
-372,694
-51% -$5.38M 0.79% 45
2015
Q1 		$10.1M Sell
723,823
-105,187
-13% -$1.45M 1.6% 7
2014
Q4 		$11.4M Sell
829,010
-208,731
-20% -$2.7M 1.66% 8
2014
Q3 		$12.7M Sell
1,037,741
-911,439
-47% -$11.4M 1.75% 6
2014
Q2 		$24.3M Sell
1,949,180
-157,461
-7% -$1.85M 1.69% 15
2014
Q1 		$23.5M Sell
2,106,641
-168,951
-7% -$1.85M 1.67% 16
2013
Q4 		$27.6M Buy
2,275,592
+446,917
+24% +$5.34M 1.52% 22
2013
Q3 		$22.3M Buy
1,828,675
+892,117
+95% +$12.4M 1.27% 36
2013
Q2 		$12.4M Buy
+936,558
New +$13M 0.76% 63

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Opus Capital Group's LFCR Position: Q3 2015 in Review

Opus Capital Group sold out of Lifecore Biomedical (LFCR) in Q3 2015, closing a stake of 351,129 shares — an estimated $5.07M sold.

Opus Capital Group first reported a position in LFCR in Q2 2013 and held it in 9 quarters. The position peaked at $27.6M in Q4 2013. 111 funds tracked by Wall St. Rank hold LFCR as of Q3 2015.

  • Opus Capital Group reported no remaining Lifecore Biomedical position as of Q3 2015 after selling out during the quarter.
  • Opus Capital Group sold 351,129 Lifecore Biomedical shares in Q3 2015, an estimated $5.07M.
  • Opus Capital Group first reported a position in Lifecore Biomedical in Q2 2013 and held it in 9 quarters.
  • Opus Capital Group's Lifecore Biomedical position peaked at $27.6M in Q4 2013.
  • 111 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2015.

Based on Opus Capital Group's 13F filing for Q3 2015, filed 6 Nov 2015.